0001558370-24-000716.txt : 20240202 0001558370-24-000716.hdr.sgml : 20240202 20240202161023 ACCESSION NUMBER: 0001558370-24-000716 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240130 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20240202 DATE AS OF CHANGE: 20240202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-PATH HOLDINGS INC CENTRAL INDEX KEY: 0001133818 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 870652870 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36333 FILM NUMBER: 24591485 BUSINESS ADDRESS: STREET 1: 4710 BELLAIRE BOULEVARD STREET 2: SUITE 210 CITY: BELLAIRE STATE: TX ZIP: 77401 BUSINESS PHONE: (832) 742-1357 MAIL ADDRESS: STREET 1: 4710 BELLAIRE BOULEVARD STREET 2: SUITE 210 CITY: BELLAIRE STATE: TX ZIP: 77401 FORMER COMPANY: FORMER CONFORMED NAME: OGDEN GOLF CO CORP DATE OF NAME CHANGE: 20010205 8-K 1 bpth-20240130x8k.htm 8-K
0001133818false00011338182024-01-302024-01-30

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

​

FORM 8-K

​

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

​

Date of report (Date of earliest event reported): January 30, 2024

​

BIO-PATH HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

​

​

​

Delaware

    

001-36333

    

87-0652870

(State or other jurisdiction of incorporation)

​

(Commission File Number)

​

(IRS Employer Identification No.)

​

​

​

4710 Bellaire Boulevard, Suite 210, Bellaire, Texas

    

77401

(Address of principal executive offices)

​

(Zip Code)

​

(832) 742-1357

(Registrant’s Telephone Number, Including Area Code)

​

(Former Name or Former Address, if Changed Since Last Report)

​

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

​

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

​

Securities registered pursuant to Section 12(b) of the Act:

​

Title of each class

    

Trading Symbol

    

Name of each exchange on which registered

Common Stock, par value $0.001 per share

 

BPTH

 

The Nasdaq Capital Market

​

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

​

Emerging growth company ☐

​

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

​

​

​

Item 5.07 Submission of Matters to a Vote of Security Holders.

As previously reported, Bio-Path Holdings, Inc. (the “Company”) convened a special meeting (the “Special Meeting”) of stockholders of the Company on January 22, 2024 at which a quorum was present.  As reported on the Company’s Current Report on Form 8-K filed on January 23, 2024, the Special Meeting was adjourned to allow the Company to solicit additional proxies in favor of an amendment to the Company’s Certificate of Incorporation to effect a reverse stock split of the Company’s common stock, par value $0.001 per share, at a ratio of up to 1-for-50, to be determined by the Board (“Proposal One”).

On January 30, 2024, the Company reconvened the Special Meeting. At the reconvened Special Meeting, the sole item of business presented to stockholders for consideration was a vote on Proposal One, which was approved by the required vote. The final voting results for Proposal One are set forth below.

Proposal One:

For the approval of an amendment to the Company’s Certificate of Incorporation to effect a reverse stock split of the Company’s common stock, par value $0.001 per share, at a ratio of up to 1-for-50, to be determined by the Board:

​

​

Shares Voted “For”

Shares Voted “Against”

Shares Withheld

Shares Abstained

Broker Non-Votes

​

3,730,378.71

3,189,585.79

--

42,153.00

--

​

​

​

​

​

SIGNATURES

​

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.

​

​

 

BIO-PATH HOLDINGS, INC.  

 

 

 

Dated: February 2, 2024

By:

/s/ Peter H. Nielsen

 

 

Peter H. Nielsen

 

 

President and Chief Executive Officer

​

​

 EX-101.SCH 2 bpth-20240130.xsd EX-101.SCH 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 bpth-20240130_lab.xml EX-101.LAB EX-101.PRE 4 bpth-20240130_pre.xml EX-101.PRE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Document and Entity Information
Jan. 30, 2024
Document and Entity Information [Abstract]  
Document Type 8-K
Document Period End Date Jan. 30, 2024
Entity File Number 001-36333
Entity Registrant Name BIO-PATH HOLDINGS, INC.
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 87-0652870
Entity Address State Or Province TX
Entity Address, Address Line One 4710 Bellaire Boulevard
Entity Address, Adress Line Two Suite 210
Entity Address, City or Town Bellaire
Entity Address, Postal Zip Code 77401
City Area Code 832
Local Phone Number 742-1357
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol BPTH
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001133818
Amendment Flag false
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1 23 1 false 0 0 false 0 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports bpth-20240130.xsd bpth-20240130_lab.xml bpth-20240130_pre.xml bpth-20240130x8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "bpth-20240130x8k.htm": { "nsprefix": "bpth", "nsuri": "http://www.biopathholdings.com/20240130", "dts": { "schema": { "local": [ "bpth-20240130.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "bpth-20240130_lab.xml" ] }, "presentationLink": { "local": [ "bpth-20240130_pre.xml" ] }, "inline": { "local": [ "bpth-20240130x8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation", "longName": "00090 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "Duration_1_30_2024_To_1_30_2024__1M8M46C9kWINnXNnt1BwA", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "bpth-20240130x8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_1_30_2024_To_1_30_2024__1M8M46C9kWINnXNnt1BwA", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "bpth-20240130x8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Document and Entity Information [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Adress Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address State Or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 14 0001558370-24-000716-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001558370-24-000716-xbrl.zip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end XML 15 bpth-20240130x8k_htm.xml IDEA: XBRL DOCUMENT 0001133818 2024-01-30 2024-01-30 0001133818 false 8-K 2024-01-30 BIO-PATH HOLDINGS, INC. DE 001-36333 87-0652870 4710 Bellaire Boulevard Suite 210 Bellaire TX 77401 832 742-1357 false false false false Common Stock, par value $0.001 per share BPTH NASDAQ false